Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock
Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock

Pharmaceuticals

Business /  Companies

Chinese start-up Everest Medicines raises US$310 million in Series C round to fund development of drugs pipeline

  • Everest focuses on developing drugs in Asia by licensing development and commercialisation rights from innovators
  • Funding from Janchor Partners, RA Capital, Hillhouse Capital, and Jiashan SDIC to help the development of eight potential drug candidates

Topic |   Pharmaceuticals
Eric Ng
Eric Ng

Updated: 3:19pm, 5 Jun, 2020

Why you can trust SCMP
Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock
Investors are pouring money into innovative Chinese drug makers, hoping to profit from the sales of new drugs in the world’s second largest pharmaceuticals market. Photo: Shutterstock
READ FULL ARTICLE